Research and Scientific Center, Sultan Bin Abdulaziz Humanitarian City, Riyadh, Kingdom of Saudi Arabia.
Johnson & Johnson Medical Devices, Somerville, New Jersey, United States of America.
PLoS One. 2020 Dec 29;15(12):e0243096. doi: 10.1371/journal.pone.0243096. eCollection 2020.
With obesity prevalence projected to increase, the demand for bariatric surgery will consequently rise. Enhanced recovery programmes aim for improved recovery, earlier discharge, and more efficient use of resources following surgery. This systematic literature review aimed to evaluate the evidence available on the effects of enhanced recovery programmes after three common bariatric procedures: laparoscopic Roux-en-Y gastric bypass (LRYGB), laparoscopic sleeve gastrectomy (LSG), and one anastomosis gastric bypass (OAGB).
MEDLINE, Embase, the Cochrane Library and the National Health Service Economic Evaluation Database were searched for studies published in 2012-2019 comparing outcomes with enhanced recovery programmes versus conventional care after bariatric surgery in Europe, the Middle East and Africa. Data were extracted and meta-analyses or descriptive analyses performed when appropriate using R.
Of 1152 screened articles, seven relevant studies including 3592 patients were identified. Six reported outcomes for 1434 patients undergoing LRYGB; however, as only individual studies reported on LSG and OAGB these could not be included in the analyses. The meta-analysis revealed a significantly shorter mean duration of hospital-stay for LRYGB enhanced recovery programmes than conventional care (mean difference [95% CI]: -1.34 days [-2.01, -0.67]; p<0.0001), supported by sensitivity analysis excluding retrospective studies. Meta-analysis found no significant difference in 30-day readmission rate (risk ratio [95% CI]: 1.39 [0.84, 2.28]; p = 0.2010). Complication rates were inconsistently reported by Clavien-Dindo grade, but descriptive analysis showed generally higher low-grade rates for enhanced recovery programmes; the trend reversed for high-grade complications. Reoperation rates were rarely reported; no significant differences were seen.
These results support enhanced recovery programmes allowing shorter inpatient stay without significant differences in readmission rate following LRYGB, although complication and reoperation rate comparisons were inconclusive. Further research is needed to fill current data gaps including the lack of studies on LSG and OAGB.
随着肥胖症患病率预计会增加,因此对减重手术的需求也会相应增加。强化康复方案旨在改善手术后的恢复情况、更早出院并更有效地利用资源。本系统文献综述旨在评估关于三种常见减重手术(腹腔镜 Roux-en-Y 胃旁路术(LRYGB)、腹腔镜袖状胃切除术(LSG)和单吻合口胃旁路术(OAGB)后强化康复方案效果的现有证据。
检索了 2012 年至 2019 年在欧洲、中东和非洲发表的比较减重手术后采用强化康复方案与常规护理的结局的研究,检索数据库包括 MEDLINE、Embase、Cochrane 图书馆和英国国家卫生服务经济评价数据库。提取数据并使用 R 进行适当的荟萃分析或描述性分析。
在筛选出的 1152 篇文章中,确定了 7 项相关研究,共纳入 3592 例患者。其中 6 项研究报告了 1434 例行 LRYGB 患者的结局,但由于只有个别研究报告了 LSG 和 OAGB 的结局,因此无法将这些研究纳入分析。荟萃分析显示,LRYGB 强化康复方案的平均住院时间明显短于常规护理(平均差值 [95%CI]:-1.34 天[-2.01,-0.67];p<0.0001),该结果通过排除回顾性研究的敏感性分析得到支持。荟萃分析发现,30 天再入院率无显著差异(风险比 [95%CI]:1.39 [0.84,2.28];p = 0.2010)。并发症发生率按 Clavien-Dindo 分级不一致地报告,但描述性分析显示强化康复方案的低级别并发症发生率通常更高;而高级别并发症的趋势则相反。再次手术率很少报告;未观察到显著差异。
这些结果支持强化康复方案,可缩短 LRYGB 患者的住院时间,而不会显著增加再入院率,但并发症和再次手术率的比较尚无定论。需要进一步研究来填补当前的数据空白,包括缺乏 LSG 和 OAGB 的研究。